NIAID COMET™ Lunaphore ACD enables multiplex sequential immunofluorescence (multiplex seqIF™)-Brand Name

This Sources Sought notice seeks information on the availability of a COMET™ Lunaphore ACD multiplex sequential immunofluorescence (multiplex seqIF™) system for the National Institute of Allergy and Infectious Diseases (NIAID) Tissue Analysis Core. The system must meet specific technical requirements, including 40-plex protocol capacity per automated run, compatibility with FFPE and frozen tissue slides, and utilization of standard-label free antibodies. Critical requirements include automated staining, image acquisition, and preprocessing, along with specific imaging and software specifications. Responses should include organizational information, business type, contract vehicle details, a capability statement (no more than six pages), place of manufacture, and evidence of authorized reseller or manufacturer status. Only Original Equipment Manufacturer (OEM) products are acceptable. Responses are due September 19, 2025, at 3:00 PM EST to michelle.cecilia@hhs.gov. This is a sources sought notice only; it does not obligate the government to award a contract.

Notice ID

34a71947048f459583ce809d7d8b7ad2

Solicitation Number

75P00125Q00069-SB

NAICS Code

325413

Classification Code

6640